[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 2
2014 1
2015 1
2017 2
2018 1
2019 3
2020 2
2021 2
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The Incredible Adventure of Omalizumab.
Domingo C, Monserrate DR, Sogo A, Mirapeix RM. Domingo C, et al. Among authors: sogo a. Int J Mol Sci. 2024 Mar 6;25(5):3056. doi: 10.3390/ijms25053056. Int J Mol Sci. 2024. PMID: 38474304 Free PMC article. Review.
Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study.
Martínez-Moragón E, Delgado J, Mogrovejo S, Fernández-Sánchez T; en nombre del grupo de investigación STEP; Los autores quieren agradecer su colaboración a los siguientes investigadores participantes ordenados alfabéticamente; Jesús JL, Ángel MOM, Patricia PM, Miguel TT, Begoña CO, Ángel FT, Purificación GD, Wilfox JRT, Brian VA, José ZYJ, Teresa ABM, Marta FJ, Nieves HMR, Marta VA, Antonio ÁFJ, Sara AS, Rosa BGM, Estela GNM, Diego AC, Núria AS, Cristina BG, Astrid CL, David RC, Jordi JP, Alejandra LG, Olga LS, Carlos MR, Pilar MO, Xavier MG, Ester PN, Francisco PC, Karina PC, Antoni RB, Luisa ROM, Dan SB, Joan SB, Pere SM, Ana SS, Lorena SR, Joan VC, Xavier VG, Ignacio AZ, Ignacio AE, Miguel HP, Milagros IPM, Carmen JM, Adolfo LC, Amaia LL, Paula LL, Joaquina PP, Vanessa ZL, Lidia AG, Pablo GMJ, Marisa MD, Teresa PM, Tahar A, Isabel AIM, Michael AO, Aurelio AM, Ignacio GN, Diego GF, Antonio LC, Luis FP, Maria MME, Félix OP, Isabela R, Antonio RPJ, Dolores SSM, Frederic TS, Alberto LN, Pedro GB, Luis GMF, Patricia MC, Manuel ECL, Marina BA, Manuel GPJ, Vanessa GP, Francisco-Javier GB, Pilar IS, Jorge MRP, Fernando MN, Ramón NO, Carracedo SM, Juan SA, Julia TR, Santiago AE, … See abstract for full author list ➔ Martínez-Moragón E, et al. Among authors: ana ss. Rev Clin Esp (Barc). 2020 Mar;220(2):86-93. doi: 10.1016/j.rce.2019.05.004. Epub 2019 Jul 23. Rev Clin Esp (Barc). 2020. PMID: 31350049 English, Spanish.
Dual Monoclonal Antibody Therapy for a Severe Asthma Patient.
Domingo C, Pomares X, Morón A, Sogo A. Domingo C, et al. Among authors: sogo a. Front Pharmacol. 2020 Sep 30;11:587621. doi: 10.3389/fphar.2020.587621. eCollection 2020. Front Pharmacol. 2020. PMID: 33101041 Free PMC article.
15 results